JPRN-jRCT2080221048未知2 期
Phase-IIa study of AJA777 in patients with functional dyspepsia
Ajinomoto Pharmaceuticals Co., Ltd.0 个研究点开始时间: 2010年3月29日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Patient showing at least one of the following 4 symptoms from more than 24 weeks before enrollment.
- •One or more of:
- •- postprandial fullness
- •- early satiation
- •- upper abdominal pain
- •- upper abdominal discomfort
排除标准
- •Patient showing symptoms of organic disease when upper gastrointestinal endoscopy is parfomed during baseline period.
研究者
相似试验
未知
2 期
Phase-II study of AJA777 in patients with functional dyspepsiaFunctional dyspepsia (recruited according to the ROME III criteria)JPRN-jRCT2080221822Ajinomoto Pharmaceuticals Co., Ltd.
未知
2 期
Phase-IIa Study of AJM300 in Patients with Active Ulcerative Colitislcerative ColitisJPRN-jRCT2080222244Ajinomoto Pharmaceuticals Co., Ltd.
未知
2 期
Phase-IIa Study of AJM300 in Patients with Active Ulcerative ColitisJPRN-jRCT2080220894Ajinomoto Pharmaceuticals Co., Ltd.
未知
3 期
Phase III study of AJG511 in patients with active ulcerative colitisulcerative colitisJPRN-jRCT2080222653EA Pharma Co.,Ltd.120
未知
2 期
Phase II study of AJG511 in patients with active ulcerative colitislcerative colitisJPRN-jRCT2080222245Ajinomoto Pharmaceuticals Co., Ltd.